TruAlt Bioenergy Limited (NSE:TRUALT)
India · Delayed Price · Currency is INR 431.20
-0.20 (-0.05%)
At close: Jul 30, 2026
TruAlt Bioenergy Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 20,505 | 17,275 | 19,077 | 12,234 | 7,624 | - | |
Revenue Growth | 1.80% | -9.45% | 55.94% | 60.47% | 45.11% | - |
Cost of Revenue | 12,865 | 11,145 | 12,760 | 8,080 | 5,031 | - |
Gross Profit | 7,640 | 6,131 | 6,317 | 4,154 | 2,593 | - |
Selling, General & Admin | 486.76 | 478.17 | 417.82 | 247.07 | 119.49 | - |
Other Operating Expenses | 3,343 | 2,755 | 2,803 | 2,024 | 1,423 | 0.12 |
Operating Expenses | 4,734 | 4,095 | 3,890 | 2,840 | 1,750 | 0.12 |
Operating Income | 2,906 | 2,035 | 2,427 | 1,314 | 842.96 | -0.12 |
Interest Expense | -1,663 | -1,600 | -1,406 | -1,362 | -345.69 | - |
Interest & Investment Income | - | - | 592.07 | 502.67 | - | - |
Currency Exchange Gain (Loss) | - | - | -0.27 | 0.77 | - | - |
Other Non Operating Income (Expenses) | 782.36 | 864.53 | -22.74 | -6.3 | -7.41 | - |
EBT Excluding Unusual Items | 2,026 | 1,300 | 1,590 | 448.73 | 489.85 | -0.12 |
Gain (Loss) on Sale of Investments | - | - | 4.26 | 0.01 | - | - |
Pretax Income | 2,026 | 1,300 | 1,594 | 448.74 | 489.85 | -0.12 |
Income Tax Expense | 511.85 | 330.85 | 128.04 | 130.66 | 135.25 | - |
Earnings From Continuing Operations | 1,514 | 968.7 | 1,466 | 318.08 | 354.6 | -0.12 |
Minority Interest in Earnings | -30.39 | -9.22 | - | - | - | - |
Net Income | 1,484 | 959.48 | 1,466 | 318.08 | 354.6 | -0.12 |
Preferred Dividends & Other Adjustments | - | - | 5.14 | 58.65 | 29.33 | - |
Net Income to Common | 1,484 | 959.48 | 1,461 | 259.43 | 325.27 | -0.12 |
Net Income Growth | -13.92% | -34.34% | 463.25% | -20.24% | - | - |
Shares Outstanding (Basic) | 82 | 78 | 70 | 61 | 46 | 0 |
Shares Outstanding (Diluted) | 82 | 78 | 70 | 61 | 46 | 0 |
Shares Change | 17.34% | 11.81% | 14.23% | 33.28% | 75023.49% | - |
EPS (Basic) | 18.14 | 12.30 | 20.94 | 4.25 | 7.10 | -2.03 |
EPS (Diluted) | 18.14 | 12.30 | 20.94 | 4.25 | 7.10 | -2.03 |
EPS Growth | -26.63% | -41.26% | 392.98% | -40.16% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -8,063 | 696.28 | -3,213 | -420.48 | -0 |
Free Cash Flow Per Share | - | -103.36 | 9.98 | -52.61 | -9.18 | -0.00 |
Gross Margin | 37.26% | 35.49% | 33.11% | 33.95% | 34.01% | - |
Operating Margin | 14.17% | 11.78% | 12.72% | 10.74% | 11.06% | - |
Profit Margin | 7.24% | 5.55% | 7.66% | 2.12% | 4.27% | - |
Free Cash Flow Margin | - | -46.67% | 3.65% | -26.27% | -5.51% | - |
EBITDA | 3,820 | 2,898 | 3,084 | 1,883 | 1,050 | 64.57 |
EBITDA Margin | 18.63% | 16.77% | 16.16% | 15.39% | 13.78% | - |
D&A For EBITDA | 913.63 | 862.28 | 656.87 | 569.17 | 207.52 | 64.69 |
EBIT | 2,906 | 2,035 | 2,427 | 1,314 | 842.96 | -0.12 |
EBIT Margin | 14.17% | 11.78% | 12.72% | 10.74% | 11.06% | - |
Effective Tax Rate | 25.26% | 25.46% | 8.03% | 29.12% | 27.61% | - |
Revenue as Reported | 21,287 | 18,140 | 19,685 | 12,802 | 7,624 | - |
Advertising Expenses | - | - | 13.7 | 2.31 | 33.55 | - |